Table 2.

Diameter of erythema at dendritic cell injection sites (mean ± SD)

(A) Longest diameter of erythema at dendritic cell injection site after first injection and at the time point with maximum reactivity
FirstMaximum
CEA (mm)40 ±1459 ± 25*
Tet34 ± 3556 ± 41
CMV7 ± 1217 ± 18
(B) Average change of diameter of erythema at dendritic cell injection site between first injection and maximum reactivity for patients with stable disease versus progressive disease
Stable disease
Progressive disease
ΔCEA (mm)34 ± 247 ± 13
ΔTet28 ± 3119 ± 20
ΔCMV12 ± 1310 ± 15
  • NOTE: Δ refers to the difference between the diameter at the first injection site and the time of maximum DTH response.

  • * P < 0.05 for comparison of diameter of response at dendritic cells + rF-CEA(6D)-TRICOM injection site for the first injection and at the maximal response using Student's t test.

  • P < 0.05 for the comparison of patients with stable disease/minor response and those with progressive disease using Student's t test.